Wednesday, October 16, 2024

NIAID Funding News, October 16, 2024

NIH/NIAID Template Banner

October 16, 2024 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-10-16

Feature Articles 

NIAID Sets Interim Paylines, Financial Management Plan for FY 2025

Remember, paylines are funding cutoff points for investigator-initiated grant applications based on score during peer review. Notably, we've already set fiscal year (FY) 2025 interim paylines for every relevant award type.

Taking a New Approach to Our Research Training Portfolio

NIAID is committed to improving the availability and effectiveness of our training, fellowship, and career development awards, to include increased support for certain research training activity codes.

Opportunities and Resources

We seek milestone-driven, early-stage translational research focused on drug discovery and development of novel therapeutics against select fungal pathogens including Candida species that remain a clinical challenge.

Submit an application to help foster, stimulate, and expand research on HIV/AIDS, HIV/AIDS comorbidities and co-infections, HIV/AIDS-associated implementation science, and HIV/AIDS-associated data science.

Recruit, mentor, and support students, postdoctoral scholars, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research or in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) programs.

In The News

Recipients of grants and cooperative agreements are now required to include in their Research Performance Progress Reports responses to several new questions that align with the Final NIH Policy for Data Management and Sharing. 

To aid researchers planning clinical trial research studies around the globe, NIAID maintains the ClinRegs database of country-specific, clinical research regulatory information for 23 countries.

News Briefs and Worth Repeating

  • With Gratitude to Dr. Hugh Auchincloss, and a Welcome to Dr. Sarah Read
  • Newcomer to NIH Funding? Attend the NIH Grants Process Primer Webinar
  • OLAW Annual Reports Are Due on December 1
  • Loan Repayment Program Application Deadline Is November 21

Advice Corner

If you or your institution receives a notification alerting you that a change was made to your application status, pay attention to the grant application number referenced in the message.

Reader Questions

New Funding Opportunities

  • PA-25-080, NIH Support for Conferences and Scientific Meetings (Parent R13, Clinical Trial Not Allowed)
  • PA-25-093, Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34, Clinical Trial Not Allowed)
  • RFA-AI-24-067, Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Systems) (U01, Clinical Trial Not Allowed)
  • NOT-OD-24-143, Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  • NOT-OD-24-179, Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp, Clinical Trial Optional)
  • RFA-AI-24-068, New Therapeutic Strategies for Genital Herpes (R21/R33, Clinical Trial Not Allowed)

Find other announcements at NIAID Opportunities and Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

$NFLX Earnings: What’s Next for Investors?

You signed up to get mail from YellowTunnel newsletter on 11/12/20.      CLICK HERE TO TAKE A.I. POWER TRADER ON A TEST DRIVE. ...